We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.00 | 14.00 | 36.00 | 25.00 | 25.00 | 25.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.86 | 37.33M |
RNS Number:4661O Cambridge Antibody Tech Group PLC 10 December 2001 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director David Chiswell 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest (i) As in 2 above (ii) As in 2 above (iii) As in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) (i) Linda Chiswell (spouse) (ii) David Chiswell (iii) Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) (i) Spouse (ii) As in 2 above (III) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary (i) Sale of 34,484 shares (ii) The purchase of 66 shares pursuant to the Cambridge Antibody Technology Inland Revenue approved All Employee Share Ownership Plan (iii) The grant of 66 "Free" matching shares pursuant to the Cambridge Antibody Technology Inland Revenue approved All Employee Share Ownership Plan 7) Number of shares/amount of stock acquired (i) Nil (ii) 66 shares (iii) 66 shares 8) Percentage of issued class (i) Nil (ii) 0.0002% (iii) 0.0002% 9) Number of shares/amount of stock disposed (i) 34,484 (ii) Nil (iii) Nil 10) Percentage of issued class (i) 0.097% (ii) Nil (iii) Nil 11) Class of security Ordinary 10p shares 12) Price per share (i) 1702p (ii) 1692p (iii) 1692p 13) Date of transaction 7 December 2001 14) Date company informed 10 December 2001 15) Total holding following this notification 441,865 16) Total percentage holding of issued class following this notification 1.244% If a director has been granted options by the company please complete the following boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information 24) Name of contact and telephone number for queries Diane Mellett 01763 263233 25) Name and signature of authorised company official responsible for making this notification Diane Mellett, Company Secretary Date of Notification 10 December 2001 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director John Aston 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest (i) As in 2 above (ii) As in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) (i) John Aston (ii) Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary (i) The purchase of 66 shares pursuant to the Cambridge Antibody Technology Inland Revenue approved All Employee Share Ownership Plan. (ii) The grant of 66 "Free" matching shares pursuant to the Cambridge Antibody Technology Inland Revenue approved All Employee Share Ownership Plan 7) Number of shares/amount of stock acquired (i) 66 shares (ii) 66 shares 8) Percentage of issued class (i) 0.0002% (ii) 0.0002% 9) Number of shares/amount of stock disposed Nil 10) Percentage of issued class Nil 11) Class of security Ordinary 10p shares 12) Price per share #16.92 13) Date of transaction 7 December 2001 14) Date company informed 10 December 2001 15) Total holding following this notification 10,666 16) Total percentage holding of issued class following this notification 0.030% If a director has been granted options by the company please complete the following boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information 24) Name of contact and telephone number for queries Diane Mellett 01763 263233 25) Name and signature of authorised company official responsible for making this notification Diane Mellett, Company Secretary Date of Notification 10 December 2001 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Cambridge Antibody Technology 2) Name of director David Glover 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of a non-beneficial interest (i) As in 2 above (ii) As in 2 above 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified) (i) David Glover (ii) Computershare Trustees Limited 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) As in 2 above 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary (i) The purchase of 66 shares pursuant to the Cambridge Antibody Technology Inland Revenue approved All Employee Share Ownership Plan (ii) The grant of 66 "Free" matching shares pursuant to the Cambridge Antibody Technology Inland Revenue approved All Employee Share Ownership Plan 7) Number of shares/amount of stock acquired (i) 66 shares (ii) 66 shares 8) Percentage of issued class (i) 0.0002% (ii) 0.0002% 9) Number of shares/amount of stock disposed Nil 10) Percentage of issued class Nil 11) Class of security Ordinary 10p shares 12) Price per share #16.92 13) Date of transaction 7 December 2001 14) Date company informed 10 December 2001 15) Total holding following this notification 12,857 16) Total percentage holding of issued class following this notification 0.036% If a director has been granted options by the company please complete the following boxes 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information 24) Name of contact and telephone number for queries Diane Mellett 25) Name and signature of authorised company official responsible for making this notification Diane Mellett, Company Secretary Date of Notification 10 December 2001
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions